Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Coflex PS3 Actual Conditions for Use Study

NCT: NCT02555280 · COMPLETED

NCT IDNCT02555280
StatusCOMPLETED
Start Date2019-09-09
Completion2026-05-31
SponsorCompanion Spine, LLC (OTHER)
First posted
Last updated

Brief Summary

A 2 and 5 year evaluation of clinical outcomes in the treatment of degenerative spinal stenosis with concomitant low back pain by decompression with additional stabilization using the coflex® Interlaminar Technology for FDA Actual Conditions of Use Study.

Frequently Asked Questions

What is Coflex PS3 Actual Conditions for Use Study?

Coflex PS3 Actual Conditions for Use Study is a clinical trial registered under NCT02555280. Current status: COMPLETED.

What is the status of NCT02555280?

The current status of NCT02555280 (Coflex PS3 Actual Conditions for Use Study) is: COMPLETED.

When did Coflex PS3 Actual Conditions for Use Study start?

Coflex PS3 Actual Conditions for Use Study started on 2019-09-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.